跳至主要内容
临床试验/NCT02853214
NCT02853214已完成不适用

Identification of Genetic Factors Predisposing to Dysglobulinemia

Hospices Civils de Lyon94 个研究点 分布在 1 个国家目标入组 1,868 人开始时间: 2008年2月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,868
试验地点
94
主要终点
Data of a bank cells, clinically annotated, from families with at least 2 cases of dysglobulinemia and at least 1 case alive.plasma cell dysplasia

研究概览

简要总结

Multiple Myeloma (MM) is a malignant proliferation of monoclonal plasma cells. Myeloma accounts for almost 14% of all hematologic cancers and is essentially incurable. Myeloma commonly evolves from a precursor disease, Monoclonal gammopathy of undetermined significance (MGUS). Despite intensive study, the etiology of MGUS and myeloma are unknown and no lifestyle or environmental exposure factors have been identified that are consistently linked to increased risk of MM, MGUS or the transition between the two.

The overall goal is to identify risk genes for dysglobulinemia, and more specifically Multiple Myeloma. This will involve the conservation of cells in a bank and genetic sequencing on samples obtained from families with at least two cases of dysglobulinemia. Material used for sequencing is likely to include fresh peripheral blood cells or lymphoblastoid lines established from peripheral blood lymphocytes of patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 2 cases per family at least
  • 1 case alive at least
  • biological material available for 1 case at least
  • Patients give their informed consent
  • attached to the French Health protection service

排除标准

  • Age under 18

结局指标

主要结局

Data of a bank cells, clinically annotated, from families with at least 2 cases of dysglobulinemia and at least 1 case alive.plasma cell dysplasia

时间窗: up to 48 months

The investigator collects blood samples from patients with dysglobulinemia and their relatives and with this, the investigators constitutes the bank cells thanks to the establishment of lymphoblastoid cell lines. The investigator considers as "dysglobulinemia" cases patients with Multiple Myeloma, MGUS, Waldenström's disease and MGUS (monoclonal gammopathy of unknown significance ) as wells as plasmacytomas confirmed histologically or cytologically.

次要结局

  • Single Nucleotide Polymorphism array for identification of polymorphisms predictive of dysglobulinemia(at day 0)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (94)

Loading locations...

相似试验